Similarly, inhibition of ADAM17 with an inhibitory antibody likewise suppressed motility in human pancreatic cancer cells in vitro and also significantly delayed tumorigenesis in a murine model [67], and ADAM17 silencing significantly suppressed hypoxia-induced migration of keratinocytes [68]. Here, ADAM17 is linked to familial pancreatic carcinoma.